153 related articles for article (PubMed ID: 17162724)
21. Dopaminergic modulation of semantic priming in healthy volunteers.
Roesch-Ely D; Weiland S; Scheffel H; Schwaninger M; Hundemer HP; Kolter T; Weisbrod M
Biol Psychiatry; 2006 Sep; 60(6):604-11. PubMed ID: 16603132
[TBL] [Abstract][Full Text] [Related]
22. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
[TBL] [Abstract][Full Text] [Related]
23. The function of dopaminergic neural signal transmission in auditory pulse perception: evidence from dopaminergic treatment in Parkinson's patients.
Geiser E; Kaelin-Lang A
Behav Brain Res; 2011 Nov; 225(1):270-5. PubMed ID: 21787806
[TBL] [Abstract][Full Text] [Related]
24. Speed of lexical activation in nonfluent Broca's aphasia and fluent Wernicke's aphasia.
Prather PA; Zurif E; Love T; Brownell H
Brain Lang; 1997 Oct; 59(3):391-411. PubMed ID: 9299070
[TBL] [Abstract][Full Text] [Related]
25. Hemispheric contributions to lexical ambiguity resolution in a discourse context: evidence from individuals with unilateral left and right hemisphere lesions.
Grindrod CM; Baum SR
Brain Cogn; 2005 Feb; 57(1):70-83. PubMed ID: 15629218
[TBL] [Abstract][Full Text] [Related]
26. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
[TBL] [Abstract][Full Text] [Related]
27. Hemispheric differences in strong versus weak semantic priming: evidence from event-related brain potentials.
Frishkoff GA
Brain Lang; 2007 Jan; 100(1):23-43. PubMed ID: 16908058
[TBL] [Abstract][Full Text] [Related]
28. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease.
Perrotta A; Serrao M; Bartolo M; Valletta L; Locuratolo N; Pujia F; Fattapposta F; Bramanti P; Amabile GA; Pierelli F; Parisi L
Clin Neurophysiol; 2005 Sep; 116(9):2091-8. PubMed ID: 16029959
[TBL] [Abstract][Full Text] [Related]
29. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
30. Unimpaired negative but enhanced positive priming in Parkinson's disease: evidence from an identity and a location priming task.
Troche SJ; Trenkwalder C; Morelli-Canelo M; Gibbons H; Rammsayer TH
Neuropsychologia; 2006; 44(10):1811-21. PubMed ID: 16620885
[TBL] [Abstract][Full Text] [Related]
31. Levodopa effect upon functional balance of Parkinson's disease patients.
Nova IC; Perracini MR; Ferraz HB
Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
[TBL] [Abstract][Full Text] [Related]
32. Phonotactic knowledge and lexical-semantic processing in one-year-olds: brain responses to words and nonsense words in picture contexts.
Friedrich M; Friederici AD
J Cogn Neurosci; 2005 Nov; 17(11):1785-802. PubMed ID: 16269114
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary functions in Parkinson's disease.
Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
[TBL] [Abstract][Full Text] [Related]
34. Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients.
Shook SK; Franz EA; Higginson CI; Wheelock VL; Sigvardt KA
Neuropsychologia; 2005; 43(14):1990-9. PubMed ID: 16243049
[TBL] [Abstract][Full Text] [Related]
35. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
[TBL] [Abstract][Full Text] [Related]
36. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
[TBL] [Abstract][Full Text] [Related]
37. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment.
Righi S; Viggiano MP; Paganini M; Ramat S; Marini P
Neuropsychologia; 2007 Oct; 45(13):2931-41. PubMed ID: 17662314
[TBL] [Abstract][Full Text] [Related]
38. Dopamine and semantic activation: an investigation of masked direct and indirect priming.
Angwin AJ; Chenery HJ; Copland DA; Arnott WL; Murdoch BE; Silburn PA
J Int Neuropsychol Soc; 2004 Jan; 10(1):15-25. PubMed ID: 14751003
[TBL] [Abstract][Full Text] [Related]
39. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
Mongeon D; Blanchet P; Messier J
Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
[TBL] [Abstract][Full Text] [Related]
40. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
